the effects of nicardipine hydrochloride , a calcium channel blocker , upon cerebrospinal fluid pressure ( csfp ) were investigated in 47 patients without intracranial pathology who were assigned to one of three groups : group 1 ( n = 17 ) , who received 0.01 mg/kg nicardipine , group 2 ( n = 17 ) , who received 0.02 mg/kg , and group 3 ( n = 13 ) , who received 0.03 mg/kg .
C0770150
nicardipine hydrochloride
C0028005
nicardipine